COST vs LLY: Which Is the Better Buy?

Side-by-side comparison of Costco Wholesale Corporation and Eli Lilly and Company β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-11.
Costco Wholesale Corporation Β· Consumer Defensive
$1,002.88
-35.4% upside to fair value
Grade C High Quality
VS
Eli Lilly and Company Β· Healthcare
$939.47
+71.1% upside to fair value
High Conviction Grade A
QuantHub Verdict
LLY has more upside to fair value (+71.1%). LLY trades at a lower forward P/E (27.4x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric COST LLY
Current Price $1,002.88 $939.47
Fair Value Estimate $648.03 $1,607.00
Upside to Fair Value -35.4% +71.1%
Market Cap $444.9B $887.6B
Forward P/E 52.1x 27.4x
EV / EBITDA 31.0x 35.8x
Price / Sales 1.6x 14.8x
Price / FCF 49.0x 107.6x
Revenue Growth YoY +3.4% +44.7%
Gross Margin 12.9% 83.8%
Operating Margin 3.8% 45.6%
Return on Equity 28.8% 77.8%
Dividend Yield 0% 0.56%
FCF Yield 2.04% 0.93%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
COST β€” Costco Wholesale Corporation
Costco Wholesale Corporation operates a global membership-based warehouse club model with over 900 warehouses across 14 countries, generating $254 billion in fiscal 2024 revenue. The company benefits from a durable competitive moat driven by scale advantages, a loyal membership base with high renewal rates, and superior employee retention through better wages and benefits. Despite steady revenue …
LLY β€” Eli Lilly and Company
Eli Lilly remains the dominant GLP-1 franchise holder with Mounjaro and Zepbound generating $36.5B combined in 2025 on 45% total revenue growth to $65.2B. The company guided $80-83B for 2026, well above prior Street consensus, and launched Foundayo (oral GLP-1, FDA approved April 2026) with $1.5B pre-built inventory. At $939 the stock trades at 14.8x P/S, right at its 5-year median, and 27.4x for…
Accumulation Zones
Metric COST LLY
Zone Low $486.02 $1,205.00
Zone High $550.83 $1,366.00
In Buy Zone? No Yes
← COST Research    LLY Research β†’    All Research